CRVS
Corvus Pharmaceuticals Inc
10.60$
-1.7%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -10.9% | -11.5% | -13.9% | -6.5% | +5.7% | +2.2% | +0.0% | -39.4% | -36.8% | -16.7% | -6.7% | -17.9% | -8.7% | -4.8% | +120.0% | -50.0% | +31.8% | – | – | +11.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -110.6% | – | – | – | -150.0% | – | – | – | – | – | – | |
| – | +18.5% | +47.8% | -8.2% | -13.3% | -9.7% | +24.9% | -19.7% | -13.8% | +0.2% | +12.2% | +13.0% | -15.5% | -0.8% | +13.9% | -22.7% | -15.8% | +8.6% | +14.4% | +10.6% | -23.2% | -31.5% | +6.5% | -3.5% | +110.5% | -60.6% | +12.6% | -13.6% | -0.1% | +0.9% | +1.9% | +1.0% | +26.9% | +14.4% | +24.8% | +5.6% | +7.4% | +17.6% | +12.4% | +42.9% | – | |
| – | -23.5% | +28.4% | +2.5% | -20.7% | +13.1% | +1.6% | +0.1% | +9.1% | +0.1% | +3.9% | +2.4% | -14.9% | +0.1% | +23.3% | -6.3% | +10.9% | -16.7% | +21.0% | -32.9% | -5.9% | -1.7% | +14.4% | -9.6% | +0.9% | -24.8% | +24.8% | -16.5% | -3.6% | +3.6% | +31.8% | -16.4% | +11.6% | +4.8% | +15.9% | -3.3% | -11.3% | +7.6% | +62.5% | -10.0% | – | |
| – | +7.4% | +44.2% | -6.4% | -14.7% | -5.8% | +20.1% | -16.3% | -9.0% | +0.2% | +10.2% | +10.5% | -15.3% | -0.6% | +16.0% | -18.9% | -8.6% | +0.3% | +16.2% | -1.7% | -19.9% | -24.7% | +8.9% | -5.4% | +77.9% | -54.6% | +16.0% | -14.5% | -1.1% | +1.6% | +10.7% | -5.1% | +22.2% | +11.7% | +22.4% | +3.4% | +3.0% | +15.3% | +22.0% | +29.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | – | +3.8% | +250.7% | -71.0% | -6.6% | -17.6% | +328.7% | -84.7% | -53.3% | -68.6% | +1,002.0% | -99.4% | -66.7% | +1,000.0% | -27.3% | +37.5% | +809.1% | +125.0% | +46.2% | +14.3% | +7.2% | +5.5% | -10.6% | -16.8% | +37.3% | +30.4% | – | – | +21.7% | +15.5% | +239.4% | -28.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -142.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -152.6% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +10,950.0% | -111.3% | – | – | -85.5% | -143.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -142.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -152.6% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -152.4% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.